Journal of Nutrition and Metabolism

Journal of Nutrition and Metabolism / 2012 / Article
Special Issue

Metabolic Syndrome: Epidemiology, Pathophysiology, and Nutrition Intervention

View this Special Issue

Clinical Study | Open Access

Volume 2012 |Article ID 215052 |

Adriana Branchi, Adriana Torri, Cristina Berra, Emanuela Colombo, Domenico Sommariva, "Changes in Serum Lipids and Blood Glucose in Non Diabetic Patients with Metabolic Syndrome after Mixed Meals of Different Composition", Journal of Nutrition and Metabolism, vol. 2012, Article ID 215052, 8 pages, 2012.

Changes in Serum Lipids and Blood Glucose in Non Diabetic Patients with Metabolic Syndrome after Mixed Meals of Different Composition

Academic Editor: Andréa Name Colado Simão
Received30 Jun 2011
Accepted21 Sep 2011
Published01 Feb 2012


Aims. To investigate the postprandial changes in serum lipoproteins and blood glucose and to verify whether different nutrient composition of the meal elicits different response in patients with (MetS+) and without (MetS−) metabolic syndrome. Research Design and Methods. 50 MetS+ patients and 50 age- and sex-matched MetS− consumed a regular lunch chosen among those more similar to their usual diet. Blood was drawn in the morning after 12-hour fasting and 2 and 4:30 hours after the meal. Results. Serum triglycerides increased more in MetS+ (35%, 4:30 hours after the meal) than in MetS− (29%), HDL-cholesterol decreased 2 hours after the meal in both groups (−4% and −5%, resp.). Blood sugar similarly increased in both groups (19%, 2 hours after the meal in MetS+ and 17% in MetS−) and plasma insulin increased more and remained high longer in MetS+ (73.5 and 52.3 μU/mL, 2 and 4:30 hours after the meal) than in MetS− (46.7 and 21.6 μU/mL). Difference in nutrient composition of the meal (carbohydrate 57%, fat 28% versus carbohydrate 45%, fat 35%) was not associated with differences in postprandial levels of triglycerides, HDL-cholesterol, glucose, and insulin within each group. Conclusions. As compared with MetS−, MetS+ patients show a greater hypertriglyceridemic and hyperinsulinemic response to a regular lunch whatever the carbohydrate or fat content of the meal.

1. Introduction

Components of the metabolic syndrome (MetS), blood sugar (BG), serum triglycerides (TGs), and HDL cholesterol (HDL-C) undergo major changes during the day as a consequence of repeated meals. Several factors have been demonstrated to influence postprandial changes of glucose and lipid variables, among them fasting levels [15] and insulin sensitivity [1, 3, 68]. Fasting levels of BG and TG are higher, insulin sensitivity is lower than normal in MetS, and therefore both BG and TG are expected to increase more in patients with MetS than in those without MetS. The magnitude and duration of the increase is however related to the nutrient composition of the meal [5]. Since humans are at most part of the day in postprandial state, the effects of diet in the short term must be taken into account, especially because a large body of evidence shows that changes in postprandial lipoprotein pattern and BG are associated with changes in cardiovascular risk [914]. It is then conceivable that the evaluation of the effects of modified diets on BG and lipoprotein profile should include the postprandial state.

Dietary recommendations [15] for the management of patients with the MetS emphasize reduction of total fat intake and its replacement with carbohydrate (CHO). Low-fat diet means lower postprandial lipemia and decrease of low-density lipoprotein cholesterol level, that is the primary target of therapy of MetS [15]. Concerns about this approach have been raised on the basis of the fact that diets low in fat are high in CHO that may have detrimental effects on BG, TG, and HDL-C. Some authors suggested that low-fat diets should be avoided in the treatment of the MetS and advocated lower intake of CHO [16]. Low-CHO diets improve insulin sensitivity, lower serum TG, and raise HDL-C [17, 18]. Diets with very low-CHO content have been shown to reduce the TG response to a fat load in normal weight men and women [1921], but not in overweight women [22]. As compared with low-CHO diets, higher-CHO diets have been reported to be associated with a greater postprandial elevation of serum TG in diabetic [23] and nondiabetic patients [24, 25]. Low-fat diet appears then to have unfavorable effects on postprandial lipoprotein profile as well as on blood glucose and plasma insulin [16], and this may have particular implications in patients with insulin resistance who have an exaggerated TG and glycemic response to the meal [7]. However, in the above mentioned studies meals had extremely high or extremely low proportions of fat and CHO. The effects of meals with less extreme variations in macronutrients and that are more suitable for long-term dietary treatment of patients with the MetS are poorly known.

We studied a group of nondiabetic patients with (MetS+) and without MetS (MetS−) in the morning before breakfast and 2 and 4:30 hours after lunch. The main purpose of the study was to investigate the changes in serum lipoprotein pattern and BG after a regular meal and to verify whether moderately different nutrient composition of the lunch elicits different response in MetS+ and MetS− patients.

2. Patients and Methods

2.1. Patients

The study was carried out on 50 patients (25 males and 25 females, 31 to 65 years) with MetS as diagnosed according to the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII) [18] and on 50- age and sex-matched patients without MetS. The patients were selected among patients hospitalized for minor illnesses in the Department of Internal Medicine of the G. Salvini Hospital in Garbagnate Milanese. All the patients were in good clinical and nutritional conditions. Pathological history of patients included chest discomfort of noncardiac origin (21), hypertension (19), paroxysmal supraventricular arrhythmias (17), syncope (14), abdominal pain (10), osteoarthritis (6), dizziness (5), anxiety attacks (5), urticaria (2), and transient global amnesia (1). The exclusion criteria were a history of thyroid disease, diabetes mellitus, hepatic and renal disfunction, neoplastic disease, current pregnancy, unstable medical condition, and the current use of medications known to affect weight, appetite, blood lipids, and glucose. One male and 3 females (3 MetS+ and 1 MetS−) were hypercholesterolemic (274, 303, 307 and 310 mg/dL) and 5 males and 2 females MetS+ were hypertriglyceridemic (246, 247, 262, 288, 298, 314, and 380 mg/dL). All patients gave their informed consent to the study protocol, which was conducted according to the guidelines of the Declaration of Helsinki and had been approved by the local Ethic Committee.

2.2. Study Design

The main purpose of the study was to evaluate the metabolic effects of meals in conditions as close as possible to everyday life. The patients followed their usual diet and the test meal was chosen among those that most resembled their habitual diet. All meals were prepared by the hospital kitchen. The patients did not consume alcoholic beverages. The patients had their breakfast (12% of daily calories: carbohydrates 71%, protein 18%, fat 11% of total energy) at 8: 00 AM and their lunch (on average 1121±17 calories, 51% carbohydrates, 18% protein, 31% fat) at 12:30 PM. The composition of meals was assessed by an accurate nutritional analysis that was made for each subject by two of us (C. Berra and E. Colombo). Quantities of intake were estimated according to a table with standardized portion sizes (Atlante Ragionato di Alimentazione, Istituto Scotti Bassani, Milan, Italy).

2.3. Analytical Methods

Blood samples were collected in the morning at 8:00 after an overnight fast and before the breakfast, at 2:30 PM and at 5:00 PM, and immediately centrifuged. Total cholesterol was measured by CHOD-PAP method, serum TG by GPO-PAP method, HDL-C by HDL-C plus method, and BG by GOD-PAP method (Roche Diagnostics GmbH, Mannheim, Germany). Measurements of serum lipids, HDL-C, and BG were done on the Hitachi 917 autoanalyzer (Boehringer Mannheim, Germany). Apolipoprotein (apo) B and A-I were determined by immuno-turbidimetric method (Roche Diagnostics GmbH, Mannheim, Germany) and plasma insulin by radioimmunoassay (Insulin RIA, Adaltis Italia S.p.A., Casalecchio sul Reno, Italy). The accuracy of determinations was assessed according to the Intra- and Inter-laboratory Quality Control Program UNITY (Bio-Rad Laboratories S.r.l., Segrate, Italy). Insulin resistance (HOMAIR) was calculated according to Matthews et al. [26].

Body mass index (BMI) was calculated by dividing weight (in Kg) for height2 (in m.). Waist circumference was measured at the level of the umbilicus and hip circumference at the level of the greater trochanters. The magnitude of postprandial changes in serum lipids, lipoproteins, BG, and insulin was estimated by calculating the incremental area under the curve (IAUC), according to the trapezoidal method after subtraction of fasting values.

2.4. Statistical Analysis

Data are presented as m e a n ± S E M . Differences between groups were analyzed with the Student’s t-test for unpaired data. Student’s t-test for paired data was used to compare data within groups. The two tailed significance threshold was set at 𝑃 < 0 . 0 5 .

3. Results

3.1. Baseline

Table 1 summarizes physical characteristics and fasting metabolic variables of the 100 patients included in the study. With respect to MetS−, MetS+ patients were more obese, had greater waist to hip ratio, and had higher baseline serum TG, apo B, Apo A-I/HDL-C ratio, BG, plasma insulin, and HOMAIR and lower HDL-C and apo A-I.

VariablesWith metabolic syndromeWithout metabolic syndrome 𝑃
m e a n ± S E M m e a n ± S E M

Age (y) 5 5 . 3 ± 1 . 1 9 5 0 . 5 ± 1 . 2 1 N.S.
Body mass index (Kg/m2) 3 0 . 1 ± 0 . 7 1 2 6 . 2 ± 0 . 5 0 <0.001
Waist girth (cm) 1 0 0 . 5 ± 2 . 0 1 8 7 . 9 ± 1 . 6 0 <0.001
Waist/Hip ratio 0 . 9 4 ± 0 . 0 1 0 . 8 9 ± 0 . 0 1 <0.01
Serum triglycerides (mg/dL) 1 7 0 . 9 ± 9 . 5 9 1 0 5 . 0 ± 5 . 0 6 <0.001
HDL cholesterol (mg/dL) 3 7 . 1 ± 1 . 2 7 5 1 . 4 ± 2 . 0 1 <0.001
Apolipoprotein A-I (mg/dL) 1 0 1 . 4 ± 3 . 2 5 1 2 5 . 9 ± 3 . 0 4 <0.001
Apo A-I/HDL-C ratio 2 . 7 8 ± 0 . 0 6 2 . 5 2 ± 0 . 0 5 <0.002
Total cholesterol (mg/dL) 2 0 6 . 0 ± 5 . 6 3 1 9 6 . 6 ± 5 . 0 5 N.S.
Apolipoprotein B (mg/dL) 1 1 1 . 9 ± 3 . 6 1 1 0 1 . 8 ± 3 . 3 7 <0.05
Glucose (mg/dL) 1 0 1 . 8 ± 2 . 8 3 8 8 . 6 ± 1 . 1 7 <0.001
Insulin (μU/mL) 1 6 . 8 ± 1 . 4 3 8 . 7 ± 0 . 8 5 <0.001
HOMAIR 4 . 2 9 ± 0 . 4 0 1 . 8 7 ± 0 . 1 6 <0.001

*Student’s t-test for unpaired data.
3.2. Postprandial Changes

As shown in Figure 1, after the lunch serum TG significantly increased in both MetS+ (29% at 2:30 PM and 35% at 5:00 PM) and MetS− patients (30% and 29%, resp.). Despite the apparent similarity of postprandial increase of TG in the 2 groups, calculation of IAUC demonstrated that the increase of TG was significantly greater in MetS+ than in MetS− (Table 2), possibly due to the longer duration of hypertriglyceridemia in MetS+ patients. In both MetS+ and MetS−, HDL-C significantly decreased at 2:30 PM (−4% and −5%, resp.) and remained significantly lower than baseline at 5:00 PM in MetS+ (−4%), but not in MetS− patients. Apo A-I did not change significantly, while Apo A-I/HDL-C ratio significantly increased only in MetS+ group (3% at 2:30 PM and 5% at 5:00 PM). BG significantly increased in both MetS+ (19% at 2:30 PM and 7% at 5:00 PM) and MetS− (17% and 5%, resp.), without differences between the 2 groups as shown by the lack of significant difference of IAUC (Table 2). Plasma insulin increased more (Table 2) and remained high longer in MetS+ than in MetS− patients (Figure 1). In neither group of patients serum cholesterol and apo B significantly changed after meal.

NumberTriglycerides mg* 9 h/dLHDL-C mg* 9 h/dLGlucose mg* 9 h/dLInsulin μU* 9 h/mL

MetS+50 3 0 1 . 3 ± 4 8 . 9 8 . 6 ± 2 . 8 9 6 . 9 ± 2 2 . 3 2 9 9 . 7 ± 3 2 . 6 x
MetS−50 1 7 9 . 9 ± 2 8 . 5 1 1 . 8 ± 5 . 6 7 3 . 0 ± 1 3 . 0 1 8 7 . 0 ± 2 3 . 0
MetS+ low CHO meal29 3 1 9 . 3 ± 6 0 . 5 9 . 4 ± 3 . 9 1 0 8 . 9 ± 3 2 . 4 2 9 6 . 1 ± 4 4 . 3
MetS+ low fat meal21 2 7 6 . 4 ± 8 2 . 5 7 . 4 ± 3 . 9 8 0 . 3 ± 2 8 . 9 3 0 4 . 6 ± 4 8 . 9
MetS− low CHO meal20 1 8 0 . 5 ± 3 6 . 2 1 0 . 5 ± 4 . 8 7 0 . 7 ± 2 4 . 9 2 1 6 . 3 ± 3 1 . 4
MetS− low fat meal30 1 7 9 . 4 ± 4 1 . 5 1 2 . 6 ± 8 . 8 7 4 . 6 ± 1 4 . 4 1 6 7 . 5 ± 3 2 . 0

𝑃 < 0 . 0 5 ; x 𝑃 < 0 . 0 1 versus MetS−.
3.3. Low Fat and Low CHO Meal

On the basis of the median of CHO content, meals were subdivided into 2 groups: in the first one CHO accounted on the average for 45% of calories and fat 35%, and in the second one CHO accounted for 57% and fat 28% of calories (Table 3). Twenty nine MetS+ (14 males and 15 females) and 20 MetS− patients (11 males and 9 females) consumed a meal low in CHO; 21 MetS+ (11 males and 10 females) and 30 MetS− (14 males and 16 females) consumed a meal low in fat. As shown in Figure 2, the difference in nutrient composition of the meal was not associated with difference in postprandial levels of serum TG, HDL-C, BG, and plasma insulin within each group of MetS+ and MetS− patients.

VariablesLow CHOLow fat 𝑃

Energy (Cal) 1 1 1 4 ± 2 2 . 5 1 1 3 8 ± 2 6 . 0 N.S.
Carbohydrate (%) 4 5 ± 0 . 6 5 7 ± 0 . 9 <0.001
Total fat (%) 3 5 ± 0 . 8 2 8 ± 0 . 9 <0.001
Saturated fat (%) 1 0 ± 0 . 5 9 ± 0 . 4 <0.02
Protein (%) 2 0 ± 0 . 5 1 5 ± 0 . 6 N.S
Cholesterol (g) 1 6 3 ± 1 3 . 1 1 0 3 ± 9 . 1 <0.001
Fiber (g) 1 4 ± 0 . 6 1 6 ± 0 . 8 <0.02

*Student’s t-test for unpaired data.

4. Discussion

Nondiabetic MetS+ patients show a greater hypertriglyceridemic response to a meal than MetS− patients. This is the main conclusion of the present study and is in accordance with a series of previous observations that include insulin resistance [1, 3, 68], obesity [1, 2, 8, 25, 27], and fasting triglyceride level [14] among the determinants of postprandial lipemia. In MetS+ patients the increase of serum TG was associated with changes in HDL particles. The reduction of HDL-C was not coupled with a significant decrease of apo A-I, suggesting a remodeling of HDL particles, characterized by a loss of cholesterol, rather than a decrease of their concentration. The increase of apo A-I/HDL-C ratio further supports this hypothesis that on the other hand was already demonstrated by Dubois et al. [28] after different amounts of fat in the usual range of ingestion.

As expected, in both MetS+ and MetS− patients, BG and insulin increased following the meal. In the fasted state BG and insulin were significantly higher in MetS+ than in MetS− patients and the difference persisted during the postprandial phase with the highest values reached 2 hours after the meal. The IAUC of glucose however was not significantly different between the 2 groups, whereas IAUC of insulin was significantly greater in MetS+ than that in MetS− patients. Hyperinsulinemia indicates insulin resistance that is the hallmark of the MetS [15] and was present in our series of MetS+ patients as shown by the high HOMAIR. Lack of a significant difference in IAUC of BG between MetS+ and MetS− patients in front of significantly greater IAUC of insulin suggests that hyperinsulinemia was sufficient to buffer in MetS+ patients the glycemic response to the meal.

Khoury et al. [29] found that IAUC of glucose after high CHO (CHO 60%, protein 20%, and fat 20%) and high protein (CHO 30%, protein 50%, and fat 20%), but not after high fat (CHO 30%, protein 20% and fat 50%), liquid formula meals was significantly greater in 10 MetS patients than that in controls. The difference in IAUC of insulin reached the statistical significance only after the high-protein meal. Patients with MetS displayed higher postprandial TG than controls with all meals; the IAUC of TG was however significantly different only after high-fat and high-protein meals, but not after high-CHO meal. The highest values of IAUC of glucose in MetS patients were observed after the high-CHO meal and the highest IAUC of TG after the high-fat meal.

In the present study, lipoprotein pattern and blood glucose did not have different response to the meal poor in CHO or in fat neither in MetS+ nor in MetS− patients. Our data are then at variance with the data of Khoury et al. [29] and with other studies showing that high-fat/low-CHO diets reduce lipid response to a meal as compared with low-fat/high-CHO diet [1921, 2325]. Several aspects must be taken into account in explaining the conflicting results, first of all the type of diets and the test meals. Studies on the effects of diet with different fat and CHO composition often used diets with extremely high or extremely low proportions of fat and CHO. Volek et al. [20] and Sharman et al. [21] in overweight and normal weight individuals observed that consumption of a very low-CHO diet (<10% of total energy) determined a lower TG response to an oral fat load than a diet low in fat (30% of energy). Compared with the low-fat diet, very low-CHO diet increased fasting LDL-C and HDL-C and decreased fasting TG and blood glucose. The effect of very low-CHO diet on fasting TG level is of considerable interest in the evaluation of postprandial lipemia since fasting TG level has been shown to be one of the most powerful predictor of postprandial lipemia in several different experimental conditions [14, 27] as well as in the present study. The lowering effect of very low-CHO diet on postprandial lipemia might then be explained, at least in part, by a decrease of fasting TG, rather than by an increase of the tolerance of a fat meal. Koutsari et al. [19] reported in a small group of normolipidemic men that after 3 days of low-CHO diet (18% of energy), TG and glucose response to a standard high-fat meal was lower than that observed after 3 days of low-fat diet (18% of total energy). Again, fasting TGs were significantly lower after the low-CHO than after the low-fat diet so the difference in basal TG may have influenced the incremental TG response to the meal. The authors however reported that total lipemic response to the fat meal was closely related to fasting TG concentration in patients following the low-fat diet but not in patients following the low-CHO diet.

Less extreme diets also showed that low-CHO diet is associated with lesser increase in postprandial TG than low-fat diet. In an observational study on diurnal capillary TG profiles in free living patients eating regular meals, both absolute and incremental changes in TG concentrations during the day were significantly correlated with CHO intake [25]. In healthy volunteers [30] and in patients with type 2 diabetes [31], 2 weeks of low-CHO diet (40% CHO, 45% fat, and 15% protein) resulted in lower TG level throughout 8–12-hour period in response to breakfast and lunch than after 2 weeks of low-fat diet (60% CHO, 25% fat, and 15% protein). Fasting TG concentration was lower after low-CHO than after low-fat diet. In our MetS+ patients eating low-fat and low-CHO meal, fasting TG level was similar, and therefore we can rule out that the lack of a difference in fasting TG may have influenced postprandial response to the meal. The same is true for MetS− group.

Our low-fat and low-CHO meals had relative proportions of fat and CHO quite different, but not so different as in the above mentioned studies, and this might explain at least in part why we did not observe differences in postprandial BG and TG levels between the 2 groups of diet. Food constituents of the meals may further contribute to explain our findings, in particular, quality of foods containing CHO which were mainly of the low-glycemic-index type [32]. Harbis et al. [33] reported just in patients with MetS that test meals with comparable amounts of fat (28-29 g) and CHO (91–94 g), but with different glucose availability, differently affected lipid levels in postprandial state. TG significantly increased after meal rich in promptly absorbable CHO foods but not after meal containing slowly digestible CHO. Glycemia and insulinemia were significantly lower after the meal with low-glycemic-index than after meal with high-glycemic-index foods. The detrimental effects of low-fat/high-CHO meal do not seem to occur when the meal is largely based on fibre-rich, low glycemic index foods as in our case.

Some limitations of our study should be noted. First, the patients were not on stable controlled diet. However, our purpose was not to study the long-term effects of diets on postprandial lipid and glucose metabolism but just to verify whether regular meals elicit different response in patients with and without MetS and whether different fat and CHO contents of the meal determined different postprandial response. It may be argued that 3 sample points do not allow an efficient analysis of postprandial lipemia and BG. Guerci et al. [34] and Carstensen et al. [3] found good correspondence between calculations of postprandial lipemia by 3-point sample analysis and 5–7 lipid determinations conventionally used in studies on postprandial lipemia. More recently, Weiss et al. [35] found that 4-hour lipemic response was highly predictive of 8-hour responses. In our study, the last sampling of serum lipids and BG was obtained after only 4:30 hours from the beginning of the lunch. Maximal response of both BG and TG occurs 2-3 hours after oral loads and the elevation of serum BG lasts for few hours whereas the elevation of TG is much longer. In a previous study on circadian triglyceridemia [36], we found that in healthy patients TGs in whole serum and in the density fraction <1.006 remained significantly higher than those in the fasted state from noon until the dinner at 7:30 PM and then increased again until midnight. In the present study, we have missed late values of postprandial serum TG. Therefore it is possible that we have underestimated duration, but not the magnitude of postprandial hypertriglyceridemia and the associated changes in HDL concentration.

In conclusion, our study demonstrates that MetS+ patients respond with exaggerated triglyceridemia and insulinemia to meals that closely reflect in percent terms the habitual diet in our population and that moderate low-fat/high-CHO and low-CHO/high fat meals are associated with similar changes in serum TG, HDL-C, blood glucose, and plasma insulin in the postprandial period. Both low-fat and low-CHO diets can then be recommended in patients with MetS without risk of undesirable effects on postprandial lipemia and glycemia, provided that meals are largely based on fiber-rich, low glycemic index foods. Long-term studies demonstrated that both diets improve fasting lipoprotein profile in patients with MetS and are effective in reducing the prevalence of the components of the MetS [37, 38]. In a 5-month study [39], we found that both low-CHO and low-fat diets, similar to meals of the present study, were effective in improving clinical and biochemical determinants of MetS; however low-CHO diet was associated with a greater decrease of serum TG and blood pressure, whereas only low-fat diet was associated with a decrease of LDL-cholesterol. Then, the choice between one or the other diet may depend on the specific presentation of the syndrome.


BG:Blood glucose
CHO:Carbohydra te
HDL-C:High-density lipoprotein cholesterol
iAUC:Incremental area under the curve
LDL-C:Low-density lipoprotein cholesterol
MetS:Metabolic syndrome
MetS−:Patients without metabolic syndrome
MetS+:Patients with metabolic syndrome


  1. A. J. H. H. M. Van Oostrom, C. Castro, J. Ribalta et al., “Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet,” European Journal of Clinical Investigation, vol. 30, no. 11, pp. 964–971, 2000. View at: Publisher Site | Google Scholar
  2. A. R. Sharrett, G. Heiss, L. E. Chambless et al., “Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides the Atherosclerosis Risk in Communities (ARIC) study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 2, pp. 275–281, 2001. View at: Google Scholar
  3. M. Carstensen, C. Thomsen, and K. Hermansen, “Incremental area under response curve more accurately describes the triglyceride response to an oral fat load in both healthy and type 2 diabetic subjects,” Metabolism, vol. 52, no. 8, pp. 1034–1037, 2003. View at: Publisher Site | Google Scholar
  4. M. J. Dekker, A. J. Wright, V. C. Mazurak et al., “Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests,” Journal of Nutritional Biochemistry, vol. 20, no. 9, pp. 694–704, 2009. View at: Publisher Site | Google Scholar
  5. M.-M. Perälä, K. A. Hätönen, J. Virtamo et al., “Impact of overweight and glucose tolerance on postprandial responses to high- and low-glycaemic index meals,” British Journal of Nutrition, vol. 105, no. 11, pp. 1627–1634, 2011. View at: Publisher Site | Google Scholar
  6. M. Castro Cabezas, C. J. M. Halkes, S. Meijssen, A. J. H. H. M. Van Oostrom, and D. W. Erkelens, “Diurnal triglyceride profiles: a novel approach to study triglyceride changes,” Atherosclerosis, vol. 155, no. 1, pp. 219–228, 2001. View at: Publisher Site | Google Scholar
  7. J. Jeppesen, C. B. Hollenbeck, M. Y. Zhou et al., “Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 3, pp. 320–324, 1995. View at: Google Scholar
  8. M. Pirro, G. Lupattelli, D. Siepi et al., “Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women,” Metabolism, vol. 50, no. 3, pp. 330–334, 2001. View at: Publisher Site | Google Scholar
  9. J. López-Miranda, P. Pérez-Martínez, C. Marín, J. A. Moreno, P. Gómez, and F. Pérez-Jiménez, “Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease,” Current Opinion in Lipidology, vol. 17, no. 2, pp. 132–138, 2006. View at: Publisher Site | Google Scholar
  10. S. Bansal, J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker, “Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women,” Journal of the American Medical Association, vol. 298, no. 3, pp. 309–316, 2007. View at: Publisher Site | Google Scholar
  11. A. F. H. Stalenhoef and J. De Graaf, “Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL,” Current Opinion in Lipidology, vol. 19, no. 4, pp. 355–361, 2008. View at: Publisher Site | Google Scholar
  12. Y. Fujioka and Y. Ishikawa, “Remnant lipoproteins as strong key particles to atherogenesis,” Journal of Atherosclerosis and Thrombosis, vol. 16, no. 3, pp. 145–154, 2009. View at: Google Scholar
  13. W. B. Kannel and R. S. Vasan, “Triglycerides as vascular risk factors: new epidemiologic insights,” Current Opinion in Cardiology, vol. 24, no. 4, pp. 345–350, 2009. View at: Publisher Site | Google Scholar
  14. L. Nalysnyk, M. Hernandez-Medina, and G. Krishnarajah, “Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature,” Diabetes, Obesity and Metabolism, vol. 12, no. 4, pp. 288–298, 2010. View at: Publisher Site | Google Scholar
  15. National Cholesterol Education Program, “Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults,” Adult Treatment Panel III Final Report 02–5215, National Institute of Health Publication, 2002. View at: Google Scholar
  16. Y. Jiménez-Gómez, C. Marín, P. Pérez-Martínez et al., “A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome,” Journal of Nutrition, vol. 140, no. 9, pp. 1595–1601, 2010. View at: Publisher Site | Google Scholar
  17. F. F. Samaha, N. Iqbal, P. Seshadri et al., “A low-carbohydrate as compared with a low-fat diet in severe obesity,” New England Journal of Medicine, vol. 348, no. 21, pp. 2074–2081, 2003. View at: Publisher Site | Google Scholar
  18. G. D. Foster, H. R. Wyatt, J. O. Hill et al., “A randomized trial of a low-carbohydrate diet for obesity,” New England Journal of Medicine, vol. 348, no. 21, pp. 2082–2090, 2003. View at: Publisher Site | Google Scholar
  19. C. Koutsari, D. Malkova, and A. E. Hardman, “Postprandial lipemia after short-term variation in dietary fat and carbohydrate,” Metabolism, vol. 49, no. 9, pp. 1150–1155, 2000. View at: Publisher Site | Google Scholar
  20. J. S. Volek, M. J. Sharman, A. L. Gómez, T. P. Scheett, and W. J. Kraemer, “An isoenergetic very low carbohydrate diet improves serum HDL cholesterol and triacylglycerol concentrations, the total cholesterol to HDL cholesterol ratio and postprandial lipemic responses compared with a low fat diet in normal weight, normolipidemic women,” Journal of Nutrition, vol. 133, no. 9, pp. 2756–2761, 2003. View at: Google Scholar
  21. M. J. Sharman, A. L. Gómez, W. J. Kraemer, and J. S. Volek, “Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men,” Journal of Nutrition, vol. 134, no. 4, pp. 880–885, 2004. View at: Google Scholar
  22. J. S. Volek, M. J. Sharman, A. L. Gómez et al., “Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women,” Journal of the American College of Nutrition, vol. 23, no. 2, pp. 177–184, 2004. View at: Google Scholar
  23. K. S. Culling, H. A. W. Neil, M. Gilbert, and K. N. Frayn, “Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 5, pp. 345–351, 2009. View at: Publisher Site | Google Scholar
  24. J. Jeppesen, P. Schaaf, C. Jones, M. Y. Zhou, Y. D. Ida Chen, and G. M. Reaven, “Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women,” American Journal of Clinical Nutrition, vol. 65, no. 4, pp. 1027–1033, 1997. View at: Google Scholar
  25. J. P. H. Van Wijk, M. C. Castro Cabezas, C. J. M. Halkes, and D. W. Erkelens, “Effects of different nutrient intakes on daytime triacylglycerolemia in healthy, normolipemic, free-living men,” American Journal of Clinical Nutrition, vol. 74, no. 2, pp. 171–178, 2001. View at: Google Scholar
  26. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at: Google Scholar
  27. P. Blackburn, B. Lamarche, C. Couillard et al., “Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance,” Diabetes Care, vol. 26, no. 12, pp. 3003–3009, 2003. View at: Publisher Site | Google Scholar
  28. C. Dubois, G. Beaumier, C. Juhel et al., “Effects of graded amounts (0–50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults,” American Journal of Clinical Nutrition, vol. 67, no. 1, pp. 31–38, 1998. View at: Google Scholar
  29. D. E. Khoury, N. Hwalla, V. Frochot, J. M. Lacorte, M. Chabert, and A. D. Kalopissis, “Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein,” Atherosclerosis, vol. 210, no. 1, pp. 307–313, 2010. View at: Publisher Site | Google Scholar
  30. F. Abbasi, T. McLaughlin, C. Lamendola et al., “High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk,” American Journal of Cardiology, vol. 85, no. 1, pp. 45–48, 2000. View at: Publisher Site | Google Scholar
  31. Y. D. I. Chen, S. Swami, R. Skowronski, A. M. Coulston, and G. M. Reaven, “Effect of variations in dietary fat and carbohydrate intake on postprandial lipemia in patients with noninsulin dependent diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 2, pp. 347–351, 1993. View at: Publisher Site | Google Scholar
  32. F. S. Atkinson, K. Foster-Powell, and J. C. Brand-Miller, “International tables of glycemic index and glycemic load values: 2008,” Diabetes Care, vol. 31, no. 12, pp. 2281–2283, 2008. View at: Publisher Site | Google Scholar
  33. A. Harbis, S. Perdreau, S. Vincent-Baudry et al., “Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects,” American Journal of Clinical Nutrition, vol. 80, no. 4, pp. 896–902, 2004. View at: Google Scholar
  34. B. Guerci, J. L. Paul, S. Hadjadj et al., “Analysis of the postprandial lipid metabolism: use of a 3-point test,” Diabetes and Metabolism, vol. 27, no. 4 I, pp. 449–457, 2001. View at: Google Scholar
  35. E. P. Weiss, D. A. Fields, B. Mittendorfer, M. A. D. Haverkort, and S. Klein, “Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test,” Metabolism, vol. 57, no. 10, pp. 1479–1485, 2008. View at: Publisher Site | Google Scholar
  36. A. Branchi, A. Rovellini, D. Sommariva et al., “Circadian plasma concentration of lipoprotein (a) and distribution of apoprotein (a) in healthy subjects,” Nutrition, Metabolism and Cardiovascular Disease, vol. 4, pp. 83–87, 1994. View at: Google Scholar
  37. K. Esposito, R. Marfella, M. Ciotola et al., “Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial,” Journal of the American Medical Association, vol. 292, no. 12, pp. 1440–1446, 2004. View at: Publisher Site | Google Scholar
  38. F. Muzio, L. Mondazzi, D. Sommariva, and A. Branchi, “Long-term effects of low-calorie diet on the metabolic syndrome in obese nondiabetic patients,” Diabetes Care, vol. 28, no. 6, pp. 1485–1486, 2005. View at: Publisher Site | Google Scholar
  39. F. Muzio, L. Mondazzi, W. S. Harris, D. Sommariva, and A. Branchi, “Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome,” American Journal of Clinical Nutrition, vol. 86, no. 4, pp. 946–951, 2007. View at: Google Scholar

Copyright © 2012 Adriana Branchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2051 Views | 705 Downloads | 5 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.